Hosted on MSN
Analysis shows udenafil significantly improves exercise capacity in Fontan patients with reduced baseline function
A newly published, post-hoc analysis of the landmark FUEL (Fontan Udenafil Exercise Longitudinal) Trial demonstrates that udenafil, a PDE5 inhibitor, significantly improves peak oxygen consumption ...
In adults with Fontan circulation, a higher pulmonary vascular resistance index (PVRI) during exercise and failure to reduce the PVRI were associated with a greater risk for death or heart ...
Management and decision making in univentricular heart disease and Fontan circulation, represents one of the most complex challenges in congenital ...
SEOUL, South Korea, Aug. 12, 2025 /PRNewswire/ -- A newly published post-hoc analysis of the landmark FUEL (Fontan Udenafil Exercise Longitudinal) Trial demonstrates that udenafil, a PDE5 inhibitor, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results